Does TOFACITINIB Cause Lymphoma? 188 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 188 reports of Lymphoma have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
188
Reports of Lymphoma with TOFACITINIB
0.1%
of all TOFACITINIB reports
18
Deaths
57
Hospitalizations
How Dangerous Is Lymphoma From TOFACITINIB?
Of the 188 reports, 18 (9.6%) resulted in death, 57 (30.3%) required hospitalization, and 16 (8.5%) were considered life-threatening.
Is Lymphoma Listed in the Official Label?
Yes, Lymphoma is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Lymphoma?
RANITIDINE (1,256)
RITUXIMAB (1,216)
ADALIMUMAB (982)
METHOTREXATE (861)
ETANERCEPT (697)
INFLIXIMAB (671)
CYCLOPHOSPHAMIDE (640)
LENALIDOMIDE (518)
PREDNISONE (490)
VINCRISTINE (422)
Which TOFACITINIB Alternatives Have Lower Lymphoma Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN